JP2015503918A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015503918A5 JP2015503918A5 JP2014550544A JP2014550544A JP2015503918A5 JP 2015503918 A5 JP2015503918 A5 JP 2015503918A5 JP 2014550544 A JP2014550544 A JP 2014550544A JP 2014550544 A JP2014550544 A JP 2014550544A JP 2015503918 A5 JP2015503918 A5 JP 2015503918A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- international
- cell
- january
- literature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161582070P | 2011-12-30 | 2011-12-30 | |
| US61/582,070 | 2011-12-30 | ||
| US201261591211P | 2012-01-26 | 2012-01-26 | |
| US61/591,211 | 2012-01-26 | ||
| PCT/US2012/072331 WO2013102219A1 (en) | 2011-12-30 | 2012-12-31 | Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015503918A JP2015503918A (ja) | 2015-02-05 |
| JP2015503918A5 true JP2015503918A5 (enExample) | 2016-02-18 |
| JP6548897B2 JP6548897B2 (ja) | 2019-07-24 |
Family
ID=48698707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014550544A Active JP6548897B2 (ja) | 2011-12-30 | 2012-12-31 | 同種異系細胞の医療用途の誘導のための方法及び組成物並びに治療的利用 |
Country Status (12)
| Country | Link |
|---|---|
| US (8) | US9803176B2 (enExample) |
| EP (2) | EP2798058B1 (enExample) |
| JP (1) | JP6548897B2 (enExample) |
| CA (2) | CA2862661C (enExample) |
| DK (1) | DK3321355T3 (enExample) |
| ES (2) | ES2656614T3 (enExample) |
| HR (1) | HRP20211373T1 (enExample) |
| HU (1) | HUE056817T2 (enExample) |
| PL (1) | PL3321355T3 (enExample) |
| PT (1) | PT3321355T (enExample) |
| SI (1) | SI3321355T1 (enExample) |
| WO (1) | WO2013102219A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2999420A1 (en) | 2005-09-27 | 2007-04-05 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
| WO2012149486A1 (en) | 2011-04-28 | 2012-11-01 | Tissuetech, Inc. | Methods of modulating bone remodeling |
| ES2822301T3 (es) | 2011-06-10 | 2021-04-30 | Tissuetech Inc | Métodos de procesamiento de tejidos de soporte fetal |
| US9982233B2 (en) | 2013-12-12 | 2018-05-29 | Samsung Life Public Welfare Foundation | Method for promoting generation of stem cell-derived exosome by using thrombin |
| WO2015142061A1 (ko) | 2014-03-18 | 2015-09-24 | 사회복지법인 삼성생명공익재단 | 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물 |
| AU2015264025A1 (en) * | 2014-05-21 | 2016-12-01 | Mimedx Group, Inc. | Micronized Wharton's jelly |
| TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
| JP6640826B2 (ja) | 2014-07-08 | 2020-02-05 | ミメディクス グループ インコーポレイテッド | 微粒子化ワルトン膠質 |
| US20160243288A1 (en) | 2015-02-23 | 2016-08-25 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
| EP3297645A4 (en) | 2015-05-20 | 2018-12-12 | Tissuetech, Inc. | Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
| JP6648259B2 (ja) * | 2015-08-12 | 2020-02-14 | チャ バイオテック カンパニー リミテッド | 向上された臍帯由来付着型幹細胞、その製造方法及びその用途 |
| US12551509B2 (en) | 2015-11-18 | 2026-02-17 | Lucina Patent Holdco, Llc | Acellular regenerative products and methods of their manufacture |
| TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
| US11318168B2 (en) * | 2016-06-24 | 2022-05-03 | Osiris Therapeutics, Inc. | Human tissue derived compositions and uses thereof |
| WO2018101782A1 (ko) | 2016-12-02 | 2018-06-07 | 가톨릭대학교 산학협력단 | T 세포 자극용 엑소좀 및 이의 약제학적 용도 |
| KR101864234B1 (ko) * | 2017-07-04 | 2018-06-04 | 인하대학교 산학협력단 | 음경해면체 유래 엑소좀을 유효성분으로 포함하는, 발기부전 예방, 개선 또는 치료용 조성물 |
| US11285177B2 (en) | 2018-01-03 | 2022-03-29 | Globus Medical, Inc. | Allografts containing viable cells and methods thereof |
| CN108239621B (zh) * | 2018-01-24 | 2020-08-18 | 北京臻溪谷医学研究中心（有限合伙） | 一种胎盘亚全能干细胞分离、扩增、冻存、复苏干细胞的方法 |
| WO2020150310A1 (en) * | 2019-01-16 | 2020-07-23 | University Of Utah Research Foundation | Use of mesenchymal stem cell sheets for preventing uterine scar formation |
| WO2020150308A1 (en) | 2019-01-16 | 2020-07-23 | University Of Utah Research Foundation | Human umbilical cord mesenchymal stem cell sheets and methods for their production |
| MX2023002726A (es) * | 2020-09-08 | 2023-05-18 | Amit Patel | Citoblastos alogenicos de cordón umbilical para el tratamiento de condiciones respiratorias graves. |
| US20230057957A1 (en) * | 2021-08-23 | 2023-02-23 | Therapeutic Solutions International, Inc. | Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and lung degeneration |
| US20230295569A1 (en) * | 2022-03-15 | 2023-09-21 | Creative Medical Technologies, Inc. | Therapeutic regenerative cells |
| US20230293598A1 (en) * | 2022-03-15 | 2023-09-21 | Narkeshyo LLC | Prevention of radiation exposure associated pathology by treatment with umbilical cord derived regenerative cells |
| US20230364148A1 (en) * | 2022-05-12 | 2023-11-16 | Therapeutic Solutions International, Inc. | Inhibition and reversion of chronic obstructive pulmonary disease (copd) by endothelial cell regeneration |
| JP2025525436A (ja) * | 2022-06-29 | 2025-08-05 | フジフィルム ホールディングス アメリカ コーポレイション | Ｉｐｓｃ由来アストロサイト及びその使用方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| ES2292245T3 (es) | 1998-05-29 | 2008-03-01 | Osiris Therapeutics, Inc. | Celulas madre mesenquimaticas cd45+ y/o fibroblasto+humanas. |
| US20030161818A1 (en) | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
| JP4790592B2 (ja) | 2003-02-11 | 2011-10-12 | ダビース，ジヨン・イー | ヒト臍帯のウォートンジェリーからの前駆細胞 |
| ES2552226T3 (es) | 2003-06-27 | 2015-11-26 | DePuy Synthes Products, Inc. | Reparación y regeneración de cartílago y hueso utilizando células derivadas posparto |
| AU2005273077B2 (en) * | 2004-08-16 | 2011-02-24 | Cellresearch Corporation Pte Ltd | Isolation of stem/progenitor cells from amniotic membrane of umbilical cord. |
| WO2007106089A1 (en) | 2006-03-14 | 2007-09-20 | Spherical Dynamics, Inc. | System for and method for psychological assessment |
| SI2120977T1 (sl) * | 2007-02-12 | 2014-01-31 | Anthrogenesis Coroporation | Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic |
| PT103843B (pt) | 2007-10-04 | 2008-08-12 | Medinfar Produtos Farmaceutico | Método de isolamento de células precursoras a partir do cordão umbilical humano |
| NZ602569A (en) * | 2008-11-21 | 2014-03-28 | Anthrogenesis Corp | Treatment of diseases, disorders or conditions of the lung using placental cells |
| CN101748096B (zh) * | 2008-12-17 | 2013-03-13 | 北京汉氏联合生物技术有限公司 | 亚全能干细胞、其制备方法及其用途 |
| CN102439136A (zh) | 2009-03-26 | 2012-05-02 | 加州大学校董 | 产生用于疾病修饰的抑制性rna的间充质干细胞 |
| WO2011038133A2 (en) * | 2009-09-23 | 2011-03-31 | Davinci Biosciences Llc | Umbilical cord lining stem cells and methods and material for isolating and culturing same |
| CN101890050B (zh) * | 2010-07-14 | 2012-07-04 | 江苏大学 | 脐带间质干细胞来源膜性囊泡及其应用 |
| EP2540819A1 (en) | 2011-06-27 | 2013-01-02 | Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) | Method for cultivating cells in platelet-lysate-containing medium |
| US20210355437A1 (en) | 2015-09-02 | 2021-11-18 | Restem Llc | Factor rich product from umbilical cord mesenchymal stem cells |
-
2012
- 2012-12-31 SI SI201231950T patent/SI3321355T1/sl unknown
- 2012-12-31 PL PL17191442T patent/PL3321355T3/pl unknown
- 2012-12-31 HU HUE17191442A patent/HUE056817T2/hu unknown
- 2012-12-31 DK DK17191442.7T patent/DK3321355T3/da active
- 2012-12-31 ES ES12862921.9T patent/ES2656614T3/es active Active
- 2012-12-31 PT PT171914427T patent/PT3321355T/pt unknown
- 2012-12-31 EP EP12862921.9A patent/EP2798058B1/en active Active
- 2012-12-31 US US13/732,204 patent/US9803176B2/en active Active
- 2012-12-31 ES ES17191442T patent/ES2890126T3/es active Active
- 2012-12-31 EP EP17191442.7A patent/EP3321355B1/en active Active
- 2012-12-31 WO PCT/US2012/072331 patent/WO2013102219A1/en not_active Ceased
- 2012-12-31 CA CA2862661A patent/CA2862661C/en active Active
- 2012-12-31 JP JP2014550544A patent/JP6548897B2/ja active Active
- 2012-12-31 CA CA3113484A patent/CA3113484A1/en active Pending
-
2017
- 2017-10-31 US US15/799,743 patent/US20190218519A1/en not_active Abandoned
-
2021
- 2021-05-17 US US17/322,672 patent/US20220041992A1/en not_active Abandoned
- 2021-08-30 HR HRP20211373TT patent/HRP20211373T1/hr unknown
- 2021-12-22 US US17/559,545 patent/US20220251514A1/en not_active Abandoned
- 2021-12-22 US US17/559,583 patent/US12441986B2/en active Active
- 2021-12-22 US US17/559,539 patent/US20220251513A1/en not_active Abandoned
-
2025
- 2025-04-02 US US19/098,979 patent/US20250346865A1/en active Pending
- 2025-09-22 US US19/335,129 patent/US20260078347A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015503918A5 (enExample) | ||
| CY1126300T1 (el) | Bcma (cd269/tnfrsf17) - πρωτεϊνες δεσμευσης | |
| BR112013012555A2 (pt) | peptídeos imunogênicos para o uso na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunes a alofatores, doenças alérgicas, tumores, rejeição a enxertos e respostas imunes contra vetores virais usados para a terapia de genes ou na vacinação de genes | |
| IL255752B (en) | Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer | |
| CY1121310T1 (el) | Χρηση πυριτικου ζιρκονιου για τη θεραπεια της υπερκαλιαιμιας | |
| JP2013517798A5 (enExample) | ||
| EA201270713A1 (ru) | Белки на основе фибронектина с каркасными доменами, которые связывают ил-23 | |
| UY29653A1 (es) | Nuevos anticuerpos anti-madcam | |
| WO2013185112A8 (en) | Pharmaceutical compositions for the treatment of cftr -mediated disorders | |
| EA201000644A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
| MX2010003574A (es) | Anticuerpos il-23. | |
| EP2987807A3 (en) | Antibodies recognising phospho-tau | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| DK2276485T3 (da) | Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom | |
| UA113609C2 (xx) | Антигензв'язуючий білок, який зв'язує людський il-23 | |
| CL2007002274A1 (es) | Compuestos derivados del acido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)-acetico; composicion farmaceutica; y uso para la prevencion y/o tratamiento de enfermedades alergicas e inmunes, tales como asma, epoc y rinitis entre otras. | |
| MX360684B (es) | Silicato de zirconio microporoso para el tratamiento de la hipercalemia. | |
| CA2862332C (en) | Anti-asic1 antibodies and uses thereof | |
| WO2012083302A3 (en) | Compositions and methods for the treatment or prevention of human adenovirus-36 infection | |
| IT1405793B1 (it) | Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente il gene, e loro uso in terapia genica | |
| EA201491513A1 (ru) | Рекомбинантные штаммы escherichia coli | |
| EA201690659A1 (ru) | Композиции аморфного магнийзамещенного фосфата кальция и их применение | |
| WO2008040190A8 (fr) | Petits peptides pour anti-angiogenèse et utilisation de ceux-ci | |
| CY1113310T1 (el) | Εξανθρωπισμενα αντισωματα ειδικα για nogo-a και φαρμακευτικες χρησεις αυτων | |
| IL222343B (en) | Compositions comprising allogeneic th1 cells and inf-gamma for treating cancer or infectious diseases |